Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer

Flexible sigmoidoscopy for colorectal cancer screening in Canada.

1Departments of Internal Medicine and Community Health Sciences, University of Manitoba; 2Department of Hematology and Oncology, CancerCare Manitoba; 3University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba; 4Division of Gastroenterology, Hepatology and Nutrition; University of Utah and Huntsman Cancer Institute, Salt Lake City, Utah; 5Division of Gastroenterology, Hepatolog...

Screening sigmoidoscopy for colorectal cancer: further pieces in the jigsaw.

Consensus is yet to be reached on the optimal approach to screening AUSTRALIANS have a 1 in 21 lifetime risk of developing colorectal cancer. 1 The incidence of the disease and mortality resulting from it can be reduced by population-based screening programs, as has been demonstrated in several large randomised controlled trials of faecal occult blood testing (FOBT). 2 The Bowel Cancer Screenin...

Flexible sigmoidoscopy for colorectal cancer screening: an evidence-based analysis.

Colorectal cancer screening with sigmoidoscopy: primary care issues.

Colorectal cancer is the second leading cause of death from cancer in the U.S., behind lung cancer. Numerous medical societies recommend routine screening for colorectal cancer with flexible sigmoidoscopy for people 50 and over. But who will perform the procedure, and who will pay for it? The case of flexible sigmoidoscopy illustrates the economic and practical issues of introducing a screening...

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

BACKGROUND The benefits of endoscopic testing for colorectal-cancer screening are uncertain. We evaluated the effect of screening with flexible sigmoidoscopy on colorectal-cancer incidence and mortality. METHODS From 1993 through 2001, we randomly assigned 154,900 men and women 55 to 74 years of age either to screening with flexible sigmoidoscopy, with a repeat screening at 3 or 5 years, or t...